Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q87901185)
Watch
English
Allogeneic transplantation in primary refractory AML
scientific article published on 24 April 2017
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
28436972
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
title
Allogeneic transplantation in primary refractory AML
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
28436972
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
author
Charles Craddock
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
28436972
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
author name string
P Ferguson
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
28436972
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
publication date
24 April 2017
1 reference
stated in
Europe PubMed Central
PubMed ID
28436972
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
published in
Bone Marrow Transplantation
1 reference
stated in
Europe PubMed Central
PubMed ID
28436972
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
volume
52
1 reference
stated in
Europe PubMed Central
PubMed ID
28436972
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
issue
7
1 reference
stated in
Europe PubMed Central
PubMed ID
28436972
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
page(s)
950-951
1 reference
stated in
Europe PubMed Central
PubMed ID
28436972
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
cites work
Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2017.61
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2017.61
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2017.61
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Primary refractory acute myeloid leukaemia - in search of better definitions and therapies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2017.61
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2017.61
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2017.61
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2017.61
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2017.61
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2017.61
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2017.61
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2017.61
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2017.61
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term outcomes of alemtuzumab-based reduced-intensity conditioned hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myelogenous leukemia secondary to myelodysplastic syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2017.61
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High alloreactivity of low-dose prophylactic donor lymphocyte infusion in patients with acute leukemia undergoing allogeneic hematopoietic cell transplantation with an alemtuzumab-containing conditioning regimen.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2017.61
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remission
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2017.61
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2017.61
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2017.61
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ipilimumab for Patients with Relapse after Allogeneic Transplantation.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2017.61
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell Transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2017.61
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/28436972
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1038/BMT.2017.61
1 reference
stated in
Europe PubMed Central
PubMed ID
28436972
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
PubMed ID
28436972
1 reference
stated in
Europe PubMed Central
PubMed ID
28436972
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
